Therapeutic advancement using multiomics and high-throughput functional screening on patient tumor-derived models of aggressive ovarian and uterine cancer

Program Type (Grant): Donor Designated

Applicant Name: Lee, Cheng-Han

Competition Cycle: 2021-04

Start Date: 2022-02-01

End Date: 2025-01-31

Institutional Sponsor: Medicine & Dentistry-Laboratory Medicine & Pathology

WCHRI Funder: RAHF

Total WCHRI Funding Commitment: $94,026.70

Funding outcome